Lumendi shines at TxIEG 2025, a record-breaking year for the company with unprecedented interest in the DiLumen Endoluminal Interventional Platform.
Lumendi shines at TxIEG 2025, a record-breaking year for the company with unprecedented interest in the DiLumen Endoluminal Interventional Platform.
Company Achieves New Milestone with 3,000 Therapeutic Procedures Completed Across U.S., Europe, and Asia Using DiLumen EIP DiLumen EZ¹ single balloon stabilization endotherapy device. (Photo: Business Wire) May 19, 2022… Continue reading Lumendi Files for 510(k) Clearance for Two New Products